- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-angiogéniques : mécanisme d’action et néphrotoxicité
Authors
Keywords
Hypertension, Nephrotoxicity, Proteinuria, Thrombotic microangiopathy, Vascular Endothelial Growth Factor targeted therapies
Journal
Nephrologie & Therapeutique
Volume 18, Issue 1, Pages 1-6
Publisher
Elsevier BV
Online
2021-11-25
DOI
10.1016/j.nephro.2021.08.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effets rénovasculaires des antiangiogéniques
- (2016) Gilbert Deray et al. BULLETIN DU CANCER
- Tolérance rénovasculaire du bévacizumab dans le cancer du sein. Valeur pronostique de l’hypertension et de la protéinurie
- (2015) Vincent Launay-Vacher et al. BULLETIN DU CANCER
- Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials
- (2015) F. Duffaud et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of the VEGF signalling pathway and glomerular disorders
- (2014) Mario Ollero et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- -Arrestin-1 Drives Endothelin-1-Mediated Podocyte Activation and Sustains Renal Injury
- (2013) S. Buelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy
- (2013) Hassan Izzedine et al. KIDNEY INTERNATIONAL
- Toxicité rénale des antiangiogéniques
- (2013) Cécile Vigneau et al. Nephrologie & Therapeutique
- The mechanisms that regulate the localization and overexpression of VEGF receptor-2 are promising therapeutic targets in cancer biology
- (2012) Kim R. Kampen ANTI-CANCER DRUGS
- Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines
- (2011) Sebastian Szmit et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF-VEGFR-2 Signaling
- (2010) K. Sison et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease
- (2010) Delma Veron et al. KIDNEY INTERNATIONAL
- An overview of small-molecule inhibitors of VEGFR signaling
- (2009) S. Percy Ivy et al. Nature Reviews Clinical Oncology
- Effets vasculaires et rénaux des médicaments anti-angiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD)
- (2008) Jean-Michel Halimi et al. Nephrologie & Therapeutique
- Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib
- (2008) G. Bollee et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiangiogenèse et cancer du rein
- (2008) Damien Pouessel et al. PRESSE MEDICALE
- Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
- (2007) J.-J. Mourad et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now